首页> 外文期刊>Chimica oggi: international journal of chemistry and biotechnology >Important elements in evaluating contract manufacturing organizations in the handling of 'potent' active pharmaceutical ingredients and products
【24h】

Important elements in evaluating contract manufacturing organizations in the handling of 'potent' active pharmaceutical ingredients and products

机译:评估合同制造组织处理“有效”活性药物成分和产品的重要要素

获取原文
获取原文并翻译 | 示例
           

摘要

It is a universal truth that research,development manufacture and formulation of potent active pharmaceutical ingredients(APIs)and products requires both "hardware"(facilities,equipment and engineering controls)and "software"(programs,practices and procedures)to adequately protect personnel and the environment.When employing third party contracting organizations,there is a need to evaluate safe processing with the same rigor as other aspects of drug development,such as quality assurance.
机译:有效的药物活性成分和产品的研究,开发制造和配方,既需要“硬件”(设施,设备和工程控制)又需要“软件”(程序,实践和程序),以充分保护人员,这是一个普遍的事实。在雇用第三方签约组织时,需要以与药品开发的其他方面(例如质量保证)相同的严格程度来评估安全加工。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号